Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2020
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative GlioblastomaAnna Esteve-Codina, Francesc Alameda, Cristina Carrato, et al.
Cell Reports. Medicine|December 20, 2023
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapyLaura Hurtado-Navarro, Ernesto José Cuenca-Zamora, Lurdes Zamora, et al.
Hemasphere|April 6, 2026
Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemiaMarta Santaliestra, Marta Garrote, María Concepción Fernández-Rodríguez, et al.
The Journal of Molecular Diagnostics : JMD|June 19, 2022
Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung CancerThomas Depoilly, Simon Garinet, Léon C van Kempen, et al.
Blood Advances|July 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasmsOriol Calvete, Julia Mestre, Lorea Chaparro-González, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in miceCarolina Vicente-Dueñas, Lorena Fontán, Ines Gonzalez-Herrero, et al.
Hemasphere|December 26, 2022
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of MyelofibrosisAdrián Mosquera-Orgueira, Manuel Pérez-Encinas, Alberto Hernández-Sánchez, et al.
Haematologica|June 15, 2023
Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosisMarine Delamare, Amandine Le Roy, Mathilde Pacault, et al.
Pageof 22